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he Arp2/3 complex and ﬁlamin A (FLNa) branch
 
actin ﬁlaments. To deﬁne the role of these actin-
 
binding proteins in cellular actin architecture, we
compared the morphology of FLNa-deﬁcient human
melanoma (M2) cells and three stable derivatives of these
cells expressing normal FLNa concentrations. All the cell
 
lines contain similar amounts of the Arp2/3 complex. Serum
addition causes serum-starved M2 cells to extend ﬂat
protrusions transiently; thereafter, the protrusions turn into
spherical blebs and the cells do not crawl. The short-lived
 
lamellae of M2 cells contain a dense mat of long actin
ﬁlaments in contrast to a more three-dimensional orthogonal
network of shorter actin ﬁlaments in lamellae of identically
T
 
treated FLNa-expressing cells capable of translational lo-
comotion. FLNa-speciﬁc antibodies localize throughout
the leading lamellae of these cells at junctions between
orthogonally intersecting actin ﬁlaments. Arp2/3 complex–
speciﬁc antibodies stain diffusely and label a few, although
not the same, actin ﬁlament overlap sites as FLNa antibody.
 
We conclude that FLNa is essential in cells that express it for
stabilizing orthogonal actin networks suitable for locomotion.
Contrary to some proposals, Arp2/3 complex–mediated
branching of actin alone is insufﬁcient for establishing an
orthogonal actin organization or maintaining mechanical
stability at the leading edge.
 
Introduction
 
A characteristic actin filament organization exists in the
lamellae of spread and translocating cells. Many actin fila-
ments overlap at high angles to one another in X-shaped
configurations, or else form T- or Y-shaped end-to-side
junctions. This arrangement, often described as orthogonal,
fills the spaces between parallel bundles of radially or cir-
cumferentially oriented actin filaments (Heuser and Kirsch-
ner, 1980; Hartwig and Shevlin, 1986; Lewis and Bridge-
man, 1992; Small et al., 1995; Svitkina et al., 1997).
The first actin filament cross-linking protein proposed to
induce orthogonal actin filament organization in mammalian
cells was filamin A (FLNa),* previously named actin-binding
protein or ABP-280. FLNa is the most widely distributed
mammalian member of a protein family also expressed in
birds and insects with paralogues in lower eukaryotes (for re-
view see Stossel et al., 2001; van der Flier and Sonnenberg,
2001). FLNa efficiently gathers actin filaments into a three-
dimensional gel in vitro by cross-linking actin filaments such
that the pointed (slow-growing) ends of actin filaments abut
 
the sides of others at high angles
 
 
 
(Hartwig et al., 1980;
Niederman et al., 1983). FLNa molecules localize specifi-
cally to many orthogonal actin filament junctions in cellular
cytoskeletons (Hartwig and Shevlin, 1986; Hartwig et al.,
1989; Hartwig, 1992; Bailly et al., 1999). However, recent
literature discounts FLNa and ascribes a predominant role of
making orthogonal actin networks at the leading edge to 70
 
 
 
branching of actin filaments by the Arp2/3 complex (for
review see Higgs and Pollard, 2001). Arrays of actin fila-
ments branching at precisely 70
 
 
 
 dominate model schemes
depicting the leading edge of cells.
An FLNa-deficient human melanoma cell line and deriva-
tive rescued sub-lines expressing approximately wild-type
FLNa concentrations, afford an opportunity to examine the
relative roles of FLNa and the Arp2/3 complex in establish-
ing and maintaining actin filament architecture in the cell
periphery. Cultured human melanoma cell lines that do not
express FLNa are more easily deformed than other mela-
noma cell lines that contain FLNa. The FLNa-null cells are
unable to migrate across porous filters in response to
chemoattractants. Under conditions expected to promote
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cell locomotion, the FLNa-deficient cells exhibit continuous
circumferential blebbing. Expression of FLNa in one of
these cell lines (M2) by transfection with FLNa cDNA
yielded sub-lines with decreased deformability that migrated
across porous filters with increasing rates in proportion to
FLNa expression levels up to the wild-type amount (Cun-
ningham et al., 1992). Although these findings strongly im-
plied that a lack of actin filament cross-linking by FLNa
leads to aberrant actin filament organization incapable of
maintaining surface stability or supporting locomotion, a di-
rect examination of actin filament architecture in FLNa-
deficient cells has been lacking.
 
Results and discussion
 
Motility of FLNa-null and -repleted cells
 
Removal of serum causes M2 cells to cease blebbing after 30
min and to remain quiescent with circumferential flat
lamellae ribbed by short filopodia. Within 10 min after the
addition of serum, the M2 cells extend a ruffling lamella
around the entire cell periphery; however, within hours
they revert to blebbing. The M2 cells at the edge of a
wounded monolayer also predominantly exhibit bleb for-
mation, but occasionally extend flat, lamellar regions that
may have small blebs at the periphery. The lamellar struc-
tures do not lead to movement of these cells into the wound
space. Therefore, M2 cells can respond to agonists with sur-
face activity, but they cannot translate their response into
directed locomotion.
M2 sub-lines expressing FLNa (A5, A7, and B3) display
polarized lamellae that actively extend filopodia and ruffles.
After serum withdrawal the cells remain asymmetric in
shape but stop ruffling. 6–10 min after serum addition the
cells resume protrusion with ruffling lamellae. The move-
ment of A5 and A7 cells across porous filters was previously
reported (Cunningham et al., 1992), and A7 and B3 cells
 
Figure 1. 
 
F-actin content and organization differ 
in flattened regions of FLNa-null and -repleted 
cells. 
 
(A) Rhodamine phalloidin staining of M2 
cells shows F-actin in lamellae 10 min after serum 
stimulation. Serum-stimulated A5 and A7 cells 
show comparatively weaker lamellar F-actin 
staining and a stronger signal in peripheral linear 
arrays. The bar graphs summarize quantification of 
rhodamine phalloidin staining of lamellar regions 
(highlighted areas in images show representative 
regions used for analysis) and of whole cells, show-
ing increased F-actin content in serum-stimulated M2 
cells relative to serum-stimulated A5 and A7 cells. 
The values are means 
 
 
 
 SEM of measurements on 
seven or more separate cells. (B). Actin cytoskele-
tons of lamellar regions of M2, A5, A7, and B3 
cells serum stimulated for 10 min and then 
prepared by quick-freeze, deep-etch electron 
microscopy. The lamellar regions of M2 cells are 
wide but thin, whereas similar regions in the other 
cell lines show more three-dimensional actin 
filament organizations. Bar, 200 nm. 
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also close a wound in vitro, moving at an average rate of 20
 
 
 
m/h.
 
Increased actin content in lamellar regions of cells 
lacking FLNa
 
Serum-starved M2 cells treated with serum for 10 min show
F-actin staining in the entire flat, lamellar region that sur-
rounds the cell periphery, and the staining reveals fine pro-
jections (Fig. 1 A). Identically treated A5 and A7 cells show
linear strands of F-actin staining throughout the cell and
around the periphery, as well as F-actin staining in lamellae
extended from discrete locations around the cell. A quantita-
tive analysis of F-actin staining reveals that the F-actin con-
tent of the lamellar regions of the M2 cells is 
 
 
 
1.8-fold
greater than that of A7 or A5 cells. Quantification of the sig-
nal over the whole cell shows a similar difference in F-actin
content between M2, A7, and A5 cells (Fig. 1 A, bar graphs).
 
Ultrastructure of M2 and A7 cells
 
Consistent with the fluorescence analysis of F-actin mass, the
density of cortical actin filaments visible in electron micro-
graphs of the broad but thin lamellae extended by M2 cells
stimulated with serum for 10 min is higher than that of fila-
ments in the more three-dimensional lamellae that predomi-
nate in identically treated A5, B3, or A7 cells (Fig. 1 B). The
lamella consists of a dense mat of interwoven filaments ori-
ented mostly perpendicular with a slight offset to the cell
edge. Similar structures were observed in flattened regions of
M2 cells at wound edges. Occasionally, filaments abut one
another and run together before separating. A few radial
bundles at the base of filopodia, corresponding to the fine
projections seen by fluorescence microscopy, intersperse with
overlapping filaments, some of which insert onto the bun-
 
dles. This filament architecture extends uniformly from the
cell edge over a distance of 
 
 
 
4 
 
 
 
m.
The peripheral actin mesh of A5, B3, and A7 cells treated
with serum for 10 min is more delicate and three-dimensional
than in the M2 lamella. Compared with the M2 cell cortical
actin cytoskeleton, the average length of filaments is shorter
and the branch angles appear higher. Therefore, the porosity
of the actin network is greater in the three-dimensional lamel-
lae of FLNa-repleted cells. These differences in the electron
microscopic appearance of actin filaments in lamellae were
consistent in 15 sets of specimens examined.
 
Levels of Arp2/3 are similar in FLNa-null and
-reconstituted cells
 
A polyclonal antibody raised against an epitope unique to
FLNa recognizes a 280-kD band on immunoblots of A5,
B3, and A7 cell lysates, but shows no reactivity with immu-
noblots of M2 cell lysates (Fig. 2 A). Fig. 2 A also shows that
a polyclonal antibody specific for FLNb detects a high mo-
lecular mass polypeptide in lysates from all of the cell lines
tested. All of the cell lysates have similar amounts of Arp2/3
complex proteins (Fig. 2 A). A more detailed analysis of M2
and A7 lysates compared with known amounts of Arp2/3
complex show no difference in the levels of Arp2/3 complex
proteins between these cells (Fig. 2 B).
 
Localization of FLNa and the Arp2/3 complex by 
immunofluorescence in A7 cells in serum
 
Arp3 immunostaining is diffuse and punctate throughout
the cytoplasm of A7 cells in serum (Fig. 2 E). The Arp3 sig-
nal intensity increases nearer the nucleus, suggesting a corre-
lation of staining intensity with cytoplasmic volume. The
Arp3 antibody also stains the lamellae of these cells. FLNa is
Figure 2.  Levels of Arp2/3 complex 
and filamin and their immunofluorescent 
distributions in M2 and derivative cells. 
(A) Cell lysates were probed with anti-
bodies that specifically recognize either 
FLNa, FLNb, or the p34Arc subunit of 
the Arp2/3 complex. M2 cells have no 
detectable FLNa signal, whereas the 
FLNa-transfected cells show strong 
immunoreactivity for this filamin 
isoform. All the cells express FLNb, and 
the lysates show equal reactivity with 
the p34Arc antibody, regardless of 
filamin level. Equal amounts of total 
protein were loaded in each lane and 
were 20 (FLNa), 40 (FLNb), and 10  g 
(p34Arc). (B) Dilutions of purified 
human platelet Arp2/3 complex and M2 
and A7 cell lysates were resolved by 
SDS-PAGE and immunoblotted with 
polyclonal antibodies directed against 
the Arp3 and p34-Arc subunits of the 
Arp2/3 complex. The experiment shown 
was obtained with p34-Arc and is 
representative of the two subunits studied. The graphs display the density of the scanned bands plotted against the amount of purified Arp2/3 
complex (inset) or M2 ( ) or A7 ( ) cell lysates obtained from a single immunoblot. (C–F) A7 cells were stained with antibodies to Arp3 (E) or 
FLNa (F). Phase contrast images (C and D) are also shown. Both Arp3 (E) and FLNa (F) immunofluorescence signals extend to the edge of 
lamellar regions of the cells and are detectable in ruffling lamellae. Bar, 5  m. 
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diffusely present throughout the cell, but localizes at the pe-
riphery of lamellae and with stress fibers that align along the
long axis of the cell body (Fig. 2 F). FLNa staining is also de-
tectable at the bases of filopodia as previously reported
(Ohta et al., 1999).
 
Localization of FLNa and the Arp2/3 complex in 
lamellae of A7 cells by electron microscopy
 
The ultrastructural analysis of FLNa localization in A7 cells
stimulated with serum for 10 min reveals FLNa molecules
throughout the periphery of the cell (Fig. 3 A). At 10 min of se-
rum stimulation the majority of the FLNa immunogold signal
localizes to the most peripheral 800 nanometers of the lamellae
(Fig. 3 D). Higher magnification views of the FLNa staining at
10 min of serum stimulation show extensive colocalization
with junctions between actin filaments (Fig. 3 C). The FLNa
gold labeling tends to occur in extended clusters, suggesting a
reaction of the polyclonal antibodies with multiple sites on the
extended FLNa subunits (Gorlin et al., 1990). No staining was
observed with secondary antibodies alone, and M2 cells
showed no staining with anti-FLNa primary antibodies.
Immunogold staining of the lamellae of serum-stimulated
A7 cells for the Arp2/3 complex gives a strong signal, ex-
tending to the periphery of the cell (Fig. 3 B). Quantitation
of the immunogold signal reveals a somewhat different dis-
tribution than that of FLNa. At 10 min of serum stimula-
tion, the Arp2/3 complex signal shows a profile of increasing
signal intensity from the periphery back toward the cell
body (Fig. 3 D).
The requirement for dodecyl sulfate denaturation of cy-
toskeletons to expose Arp3 epitopes reactive with available
antibodies has hitherto hindered more direct comparisons of
their location to those of FLNa, because the denaturation
step interferes with binding of many FLNa antibodies, in-
cluding those used for the experiments described in Fig. 3.
We determined that a combination of two monoclonal anti-
FLNa antibodies report FLNa in sodium dodecyl sulfate–
treated A7 cells by immunofluorescence and immunogold
staining and showed no staining in identically prepared M2
cells. These antibodies, generated against human platelet fil-
amin antigen, are specific for FLNa (van der Ven et al., 2000).
As expected from the results with separate staining protocols,
Figure 3. Immunogold electron micro-
scopic analysis of FLNa and Arp2/3 
localization in A7 cell lamellae. The 
insets show lower magnification images of 
cells from which the high-magnification 
views were taken. Serum-starved A7 
cells were treated with serum for 10 min, 
and then processed for immunogold 
electron microscopy using polyclonal 
antibodies to FLNa (A) or Arp3 (B). In B, 
the specimen was treated with sodium 
dodecyl sulfate. Both antibodies label 
actin filaments throughout the lamella 
right up to the edge of the cell, and the 
inset (D) displays this information 
quantitatively. Panel A and inset C 
reveal that linear clusters of gold 
localize FLNa at actin filament
junctions. Bars: (A and B) 100 nm; 
(insets, A and B) 1  m; (inset, C)
100 nm. 
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FLNa and the Arp2/3 complex localize with actin filaments
in the periphery of A7 cells (Fig. 4). However, by using gold
beads of different sizes, unique aspects of staining are appar-
ent. First, as observed with the polyclonal anti-FLNa anti-
bodies, the monoclonal antibodies often reveal beads lining
up more or less in rows at interfilament junctions, consistent
with an array along FLNa subunits attached to the sides of
filaments near the junctions to hold them in place. Second,
Arp3 staining reveals more compact structures, sometimes at
filament–filament junctions, but Arp3 and FLNa staining is
infrequently visible at the same filament overlap sites. A
quantitative analysis of the staining reveals that for both A7
and B3 cells, the majority of the immunolabeled junctions
show staining for FLNa alone (inset). Some junctions con-
tain only Arp2/3 complex, and a small minority of junctions
are stained with both FLNa and Arp2/3.
In this paper, we have documented that the functional im-
pairment of FLNa-deficient M2 cells is manifest in the pres-
ence of normal amounts of the Arp2/3 complex. The lamel-
lae of M2 cells have a very different actin organization from
FLNa-repleted cells. The extended lamellae contain in-
creased amounts of filamentous actin, and the actin fila-
ments extend in parallel over long distances, are highly inter-
penetrated, and form a dense flat mat. In contrast, the
periphery of spread FLNa-containing cells contains a much
more delicate and orthogonal three-dimensional lattice.
Consistent with the importance of an orthogonal web for lo-
comotion, M2 cells do not crawl. To flatten and spread, M2
cells, lacking FLNa, polymerize more actin than FLNa-con-
taining cells, and the higher actin concentrations create a
 
dense meshwork of long filaments presumably strengthened
by other actin filament cross-linking proteins.
To protrude the cell surface, an assembled actin lattice
must be sufficiently rigid to exert or maintain directionality
of the protruding force. A branched structure, like a tree,
can be rigid, but in order for a tree to behave as a solid the
branches themselves as well as the branch-to-branch joints
must be inflexible. Images of unperturbed actin filaments up
to a micron or so long can appear straight, but longer fila-
ments bend, and views of actin filaments extending for sev-
eral microns off of 70
 
 
 
Arp2/3-actin junctions reveal consid-
erable filament curling (Weaver et al., 2001). Because of this
flexibility, branched, but not otherwise cross-linked actin fil-
aments, are unable to maintain a rigid structure under stress
over the many microns encompassed by a leading lamella.
Linking together of branched filaments could provide the
requisite elasticity.
Although some 70
 
o
 
 actin filament branches are detectable
in a dense actin network revealed in cytoskeletons of kera-
tocytes and fibroblasts, such junctions are only readily iden-
tified by removing considerable actin filament mass that
otherwise obscures these structures (Svitkina and Borisy,
1999). Without such sample preparation, antibody labeling
of the Arp2/3 complex has been evident throughout the cell
lamellae without defining any particular structures (Bailly
et al., 1999; Svitkina and Borisy, 1999). Our results stain-
ing M2 and A7 cells are consistent with the earlier findings.
Arp2/3 complex staining, done with the same antibody and
sample preparation techniques used by previous investiga-
tors, was detectable everywhere in the spread lamellae of
Figure 4.  Double labeling of FLNa and Arp3 in a sodium dodecyl sulfate–treated A7 cytoskeleton. A7 cells grown in serum were perme-
abilized, and then labeled with two separate monoclonal antibodies to FLNa (10-nm gold beads) and a polyclonal antibody against Arp3 
(5-nm gold beads, highlighted by circles). Both antibodies label actin filament junctions at the cell periphery. Quantitation of the labeled 
junctions in A7 cells (shaded bars) and B3 cells (unshaded bars) reveals that the FLNa and Arp3 signals rarely overlap and are most often 
distinct (inset). The values are means   SEM of measurements on four or more separate cells. Bar, 100 nm. 
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M2 and A7 cells, often in aggregates, and at some actin fila-
ment junctions.
Filamin molecules have been localizable by immunocy-
tochemistry at actin filament crossover junctions in cortical
cytoskeletons, without having to resort to any special actin
extraction procedures (Hartwig and Shevlin, 1986; Hartwig
et al., 1989; Hartwig, 1992; Bailly et al., 1999). Using two
different sample preparation techniques, we have shown here
that polyclonal and monoclonal antibodies specific for FLNa
label actin filament junctions throughout the lamella up to
the plasma membrane of A7 cells. One exception to the oth-
erwise consistent localization of FLNa at peripheral actin fila-
ment junctions is a reported failure of immunogold staining
of peripheral actin filament junctions in cytoskeletons of hu-
man fibroblasts. This experiment used a monoclonal anti-fil-
amin antibody generated in our laboratory, and produced a
reaction with a few actin filament junctions far from the
plasma membrane (Svitkina and Borisy, 1999). We have also
not been able to label cortical actin cytoskeletons with that
antibody, and therefore ascribe the negative results reported
as purely technical in origin. Residence of FLNa molecules at
the cell edge is in accordance with the numerous partnerships
between FLNa and plasma membrane proteins (for reviews
see Stossel et al., 2001; van der Flier and Sonnenberg, 2001).
FLNa binds many cellular components, including signal-
ing intermediates and membrane receptors, and abnormal
functioning of these binding partners is manifest in FLNa-
null melanoma cells (Stossel et al., 2001; van der Flier and
Sonnenberg, 2001). Although indirect effects of FLNa defi-
ciency based on changes in these interactions are possible,
the diminished viscoelasticity and the striking blebbing
phenotype of stimulated M2 cells strongly point to an im-
pairment in mechanical stability of the actin filaments un-
derlying the membrane. The ability of FLNa to cross-link
actin filaments efficiently in vitro implicates FLNa as an
important component for the direct establishment of
proper actin filament organization.
The Arp2/3 complex unquestionably causes actin filament
branching, but such branching is not sufficient to maintain
three-dimensional orthogonal networks. Conversely, FLNa
produces orthogonal actin networks in vitro without the in-
termediacy of Arp2/3 complexes (Hartwig et al., 1980; Nie-
derman et al., 1983). Therefore, the Arp2/3 complex is not a
requirement for determining this kind of actin network
structure, although it may importantly contribute to the
spatial and temporal regulation of that process in vivo (Bailly
et al., 2001; Higgs and Pollard, 2001).
 
Materials and methods
 
Cell lines and culture conditions
 
Cell line M2 and M2-derived lines A5 and A7 have been described previ-
ously (Cunningham et al., 1992; Cunningham, 1995). Another sub-line, B3
of M2, expressing FLNa under direction of a cytomegalovirus promoter,
was a gift of Sue Ann Woo and Dr. John Blenis (Department of Cell Biol-
ogy, Harvard Medical School, Boston, MA). Cells were grown on glass
coverslips coated with poly-
 
D
 
-lysine (0.52 
 
 
 
g/cm
 
2
 
) in MEM containing 8%
calf serum, 2% fetal calf serum, 10 mM Hepes, pH 7.6, and 0.5 mg/ml
G418 (GIBCO BRL). For migration assays, confluent monolayers were
wounded with a pipette tip to form gaps of 
 
 
 
 350 
 
 
 
m, and video micros-
copy images were collected every 5 min for 16 h. Wound dimensions and
cell motility rates were calculated using the NIH Image program.
 
Antibodies and western blot analysis
 
Rabbit polyclonal IgG antibodies generated against peptides specific to the
first hinge domain of human FLNa (residues 1761–1777) and against the first
hinge domain of human FLNb (residues 1717–1733) were affinity purified
using the peptide antigens bound to Sepharose 2B. Antibodies were tested
for isoform specificity using the same peptides and recombinant FLNa in
binding and competition experiments. Two IgG monoclonal anti-FLN anti-
bodies (MAB 1680 and MAB 1678) were purchased from Chemicon, Inc.
Anti-FLN IgGs were used at 1:1,000 dilutions for immunoblotting and at
1:100 dilutions for immunofluorescence or immunogold labeling. Rabbit
polyclonal antibodies to the Arp3 and p34Arc subunits of the human Arp2/3
complex (Welch et al., 1997) were provided by Dr. Matthew Welch (Uni-
versity of California, Berkeley, CA) and were used at 1:50 dilution for cell
staining. The Arp2/3 complex, purified from human platelets by a modifica-
tion of the method of (Egile et al., 1999), was a gift from Dr. Fumihiko Naka-
mura (Brigham and Women’s Hospital, Boston, MA). Lysates were prepared
for immunoblotting by harvesting cells at 80% confluency from 10-cm
dishes. Cells were trypsinized, suspended in serum-containing media, cen-
trifuged and washed with PBS to remove serum proteins, and suspended in
homogenization buffer (20 mM Tris buffer, pH 7.6, 1 mM EGTA, 0.5 mM
MgSO
 
4
 
, 10 
 
 
 
g/ml leupeptin, 5 
 
 
 
g/ml pepstatin A, 10 
 
 
 
g/ml aprotinin, 0.2
mM AEBSF [4-{2-aminoethyl}benzenesulfonyl fluoride]). Cells were homog-
enized by 20 passes with a small-volume Teflon-on-glass Dounce homoge-
nizer and by two freeze–thaw cycles. Total protein was determined by the
Bradford assay calibrated with a BSA standard curve. Varying dilutions of
cell lysates or of purified platelet Arp2/3 complex were loaded onto 7.5%
(FLNa and FLNb) or 10% (Arp2/3) polyacrylamide gels with a 4% stacking
gel for SDS-PAGE. Proteins were electrophoretically transferred onto nitro-
cellulose paper, and blots were stained with 0.1% wt/vol Ponceau S in 1%
acetic acid to verify equal loading and transfer. Ponceau S was removed
with sequential rinses of TBS-Tween (50 mM Tris buffer, pH 7.6, 150 mM
NaCl, 0.05% Tween 20), and the blots were blocked in 5% nonfat dry milk
in TBS-Tween. Antibodies were diluted in 5% nonfat dry milk in TBS (50
mM Tris base, pH 7.6, 150 mM NaCl) and blots were rinsed in TBS-Tween.
Primary antibodies were detected with an HRP-conjugated goat anti–rabbit
IgG secondary antibody (Promega), and the secondary antibodies detected
with an enhanced chemiluminescence system (Pierce Chemical Co.).
 
Immunofluorescence microscopy
 
Cells were rinsed with PBS, followed by fixation with 3.7% paraformalde-
hyde, 5 mM MgCl
 
2
 
, 10 mM EGTA, and 0.1% saponin in PBS for 10 min,
rinsed three times in PBS, and then permeabilized with 0.3% Triton X-100 in
PBS for 5 min and washed three times with PBS before staining with the
polyclonal anti-FLNa antibody. For staining of cells with the polyclonal anti-
body against Arp3 and the Chemicon monoclonal antibodies against FLNa,
cells were fixed with 1% glutaraldehyde in PHEM buffer, pH 6.9 (60 mM
Pipes, 25 mM Hepes, 10 mM EGTA, 2 mM MgCl
 
2
 
), with 0.1% saponin for
10 min, washed with PBS, treated with 0.1% sodium dodecyl sulfate in
PHEM buffer for 1 min, and rinsed with PHEM buffer. Reactive aldehydes
were blocked with 1 mg/ml sodium borohydride in PHEM buffer for 2 min,
and removed by washing three times with 0.5% BSA in PBS. Fixed cells
were incubated for 1 h at room temperature in blocking solution (5% BSA in
PBS). Primary and rhodamine- or fluorescein-labeled anti–rabbit secondary
antibodies (Jackson ImmunoResearch Laboratories) were diluted in 1% BSA
in PBS and incubated with cells either overnight at 4
 
 
 
C (primary antibody)
for 2 h at room temperature (secondary antibody). Phalloidin, either labeled
with TRITC or FITC, was included in the secondary antibody incubation at a
concentration of 250 nM to label actin filaments according to the phallo-
toxin product protocol provided by Molecular Probes. Coverslips with
stained cells were mounted with Vectashield anti-bleaching media (Vector
Laboratories) and viewed on a Nikon Diaphot 300 inverted microscope
equipped with epifluorescence. Images were captured with a Micromax
cooled CCD camera (1300 
 
  
 
1030; Roper Scientific) driven by Inovision
image processing software on an SGI O
 
2
 
 computer. Images were processed
and compiled using Adobe Photoshop 5.0. NIH Image was used for quantifi-
cation, and all data were analyzed using the Kaleidagraph program. Pixels
were not saturated, and images were taken at the same exposure time so that
background intensities were matched. Images were thresholded and se-
lected for analysis using the feature analysis routine, which defined the
lamella or whole cell from the background. The output of the selection was
compared with the original image to confirm that either the lamella or the
entire cell had been selected for analysis. The sum of the intensity of the re-
gion was calculated and output to a text file for further analysis.
 
Electron microscopy
 
Cytoskeletons were prepared from M2 and A7 cells and processed for 
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electron microscopy by washing with PHEM, extraction with 0.75% Triton
X-100 in PHEM buffer containing 1 
 
 
 
M phalloidin and 0.01% glutaralde-
hyde for 2 min, and washing with PHEM followed by fixation with 1% glu-
taraldehyde in PHEM containing 0.1 
 
 
 
M phalloidin for 10 min.
In labeling experiments using the polyclonal anti-Arp3 or monoclonal
anti-FLNa antibodies, the cytoskeletons were treated with dodecyl sulfate
and unreacted aldehydes blocked as described for immunofluorescence
staining. The secondary antibodies were 5- or 10-nm gold-conjugated
anti–rabbit or anti–mouse IgGs (Ted Pella).
Gold-labeled cytoskeletons were rapidly frozen on a helium-cooled
copper block, freeze dried at 
 
 
 
85
 
 
 
C in a Cressington freeze-fracture ma-
chine (CFE-50; Ratford), and rotary coated with 1.4 nm of tantalum/tung-
sten followed by 3 nm of carbon without rotation. Replicas were floated
off using 25% hydrofluoric acid, water washed, and collected on 200
mesh copper grids coated with formvar. Grids were photographed in a
JEOL 1200-EX electron microscope at 100 kV.
To quantify the immunogold distribution in the lamellae of A7 and B3
cells, rectangular masks of 1 
 
 
 
m 
 
 
 
 0.4 
 
 
 
m were laid over images, and all
gold beads within the rectangle manually counted (the total area counted
in each lamella was 2.4 
 
 
 
m
 
2
 
).
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